Sort
21,453 grants matching “tuberculosis”
IFNGR Down Regulation as a Host Target for Therapy of Infectious Diseases
$237,750Laurel L Lenz · National Jewish Health · R21 · FY2012 · AI
Glutamine metabolism in tuberculosis
$237,704Lanbo Shi · Rbhs-New Jersey Medical School · R21 · FY2022 · AI
A Second-Generation Patch Test for Tuberculosis
$237,679Sequella, Inc. · U01 · FY2003 · AI
Clinical and epidemiological studies of Visceral Leishmaniasis in Bihar, India
$237,619Shri P Singh · Banaras Hindu University · P50 · FY2009 · AI
The Universidade Eduardo Mondlane/UCSD Medical Education Partnership
$237,600Emilia Virginia Noormahomed · Eduardo Mondlane University · R24 · FY2014 · TW
Core B Computational Modeling and Analysis
$237,581Douglas A Lauffenburger · Univ Of Massachusetts Med Sch Worcester · P01 · FY2025 · AI
A Randomized Trial of a Four Month Moxifloxacin-based Regimen for Treatment of
$237,512Marcus Barreto Conde · Johns Hopkins University · U19 · FY2008 · AI
CDI MEDIATED CONTROL OF INFECTION AND AUTOIMMUNITY
$237,481University Of Chicago · R01 · FY2001 · AI
Host-Pathogen Interactions and M.tb Drug Resistance
$237,461Gilla Kaplan · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2006 · AI
Technology Core: Metabolomics and Biochemistry
$237,448Kyu Y Rhee · Harvard School Of Public Health · U19 · FY2017 · AI
The Genetic Basis of Bone Disease in Mycobacterial Infection
$237,381David M. Tobin · Duke University · R21 · FY2016 · AI
CAfGEN Administrative Centre
$237,346Gabriel Anabwani · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2018 · AI
The human lung and lung-draining lymph node response to Mycobacterium tuberculosis
$237,296Roshni Roy Chowdhury · University Of Chicago · R21 · FY2023 · AI
Optimization of novel inhibitors of mycolic acid synthesis as TB drug candidates.
$237,288Kyle H Rohde · University Of Central Florida · R21 · FY2024 · AI
Structure of Malaria Parasite RNA polymerase
$237,285Katsuhiko Murakami · Pennsylvania State University, The · R21 · FY2022 · AI
Correlates of protection from TB and TB/AIDS comorbidity
$237,215Smriti Mehra · Louisiana State Univ A&M Col Baton Rouge · R21 · FY2016 · AI
Pilot study of linezolid for early syphilis treatment
$237,175Jeffrey David Klausner · University Of Southern California · R21 · FY2023 · AI
GLYCOPROTEINS OF MYCOBACTERIUM TUBERCULOSIS
$237,107Colorado State University-Fort Collins · R01 · FY2003 · AI
Identifying novel resistance mechanisms in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)
$237,023John Sfakianos · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · CA
Exploration of the Mycobacterial Cell Envelope Proteome by Protein Labeling in Live Cells
$237,000Jessica Chuang Seeliger · State University New York Stony Brook · R21 · FY2016 · AI
Defining the role of toxin-antitoxin systems in persistence of Burkholderia pseudomallei
$237,000Alfredo G Torres · University Of Texas Med Br Galveston · R21 · FY2020 · AI
Multidimensional Analysis of Immune Status of Latent M. Tuberculosis Infection
$237,000Yueh-Hsiu Chien · Stanford University · R21 · FY2016 · AI
Modulation of Human Immunity by Mycobacterium leprae
$237,000Claudia M.a. Manca · Univ Of Med/Dent Of Nj-Nj Medical School · R21 · FY2012 · AI
University of California, Berkeley (UCB)/University of *
$237,000University Of California Berkeley · D43 · FY2005 · TW
Signal Transduction and Latency in M. tuberculosis
$237,000Children'S Hospital Boston · R21 · FY2003 · AI